Exelixis, Inc.
USD54.77
+1.54 (+2.89%)
CEO
Michael Morrissey
IPO Date
2000-04-17
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$53.28
Prev. Close
$53.23
Day Low
$53.08
Day High
$55.15
52W Low
$33.76
52W High
$55.15
Market Cap
$13.77B
Volume
6.93M
| 9,812 |
| $50.14 |
| 29 May 2026 | PAPADOPOULOS STELIOS | director | A-Award | Acquired | 8,367 | $0.00 |
| 29 May 2026 | Heyman Tomas J. | director | A-Award | Acquired | 8,367 | $0.00 |
| 29 May 2026 | Eckhardt Sue Gail | director | A-Award | Acquired | 8,367 | $0.00 |
| 29 May 2026 | Smith Julie | director | A-Award | Acquired | 8,367 | $0.00 |
| 29 May 2026 | Freire Maria C | director | A-Award | Acquired | 8,367 | $0.00 |
| 29 May 2026 | Beckerle Mary C | director | A-Award | Acquired | 8,367 | $0.00 |
| 29 May 2026 | Oliver Bob | director | A-Award | Acquired | 8,367 | $0.00 |
| 29 May 2026 | WYSZOMIERSKI JACK L | director | A-Award | Acquired | 8,367 | $0.00 |
| 27 Apr 2020 | Donna Shalala | Donna Shalala | Sale (Partial) | $1,001 - $15,000 |
| 27 Apr 2020 | Donna Shalala | Donna Shalala | Purchase | $1,001 - $15,000 |
| 27 Apr 2020 | Donna Shalala | Donna Shalala | Purchase | $1,001 - $15,000 |